Translating Orthogonal Biology Into Cutting-Edge Biotech Companies
Khanda is a biotech company builder. We create companies that advance orthogonal biology-based approaches and shape the development of much needed medicines for chronic conditions where patients are running out of options.
A New Model for Biotech Company Creation
Across therapeutic areas, today’s drug development keeps circling familiar ground, targeting one pathway at a time, leaving unmet needs for patients who have few viable paths forward.
Khanda helps translate validated and emerging biological insights into biotech companies, each designed to unite orthogonal pathways with rigor and precision. Our agile model lets us pursue scientific combinations other companies cannot or will not, accelerating real options for conditions that standard approaches have left behind.
Our vision is a future where biological insight reliably becomes therapy, changing the course of chronic disease and relieving its burden on patients.